HealthTree Logo
search more_vert
person Sign In / Create Account

Polycythemia Vera is a chronic condition that can't be cured. However, with proper management and treatment, individuals with Polycythemia Vera can lead normal lives. The life expectancy for patients with Polycythemia Vera varies greatly and depends on various factors such as age, overall health, and how well the disease is managed. Some studies suggest that with proper treatment and management, the median survival can be more than 14 years.

What do statistics say about the life expectancy for someone with Polycythemia Vera?

According to a study published in the American Journal of Hematology, the median survival for patients with Polycythemia Vera is 13.5 to 14.5 years. However, it's important to note that these statistics are based on median values, meaning that half of the patients live longer than this. Furthermore, these statistics are based on data from patients who were diagnosed and treated several years ago, and advances in treatment may result in better prognosis for patients diagnosed today.

What factors affect prognosis for Polycythemia Vera?

  • Age: Older age at diagnosis is associated with a shorter survival time.
  • Overall health: Patients with other serious health conditions may have a poorer prognosis.
  • Disease management: How well the disease is managed can significantly affect prognosis. This includes regular monitoring and treatment to maintain a normal blood count.
  • Response to treatment: Patients who respond well to treatment typically have a better prognosis.
  • Development of complications: Complications such as blood clots, bleeding, or progression to more serious blood disorders can negatively affect prognosis.

Prognosis for Polycythemia Vera can be influenced by a variety of factors. Age plays a significant role, with older patients generally having a shorter survival time. The overall health of the patient can also impact prognosis, with those having other serious health conditions typically having a poorer outlook. The management of the disease is crucial, with regular monitoring and treatment to maintain a normal blood count being key to a better prognosis. The patient's response to treatment also plays a role, with those responding well typically having a better outlook. Finally, the development of complications such as blood clots, bleeding, or progression to more serious blood disorders can negatively affect prognosis.

Having a specialist on your team provides you with the best way of truly understanding your prognosis. Visit HealthTree's Polycythemia Vera Specialist Directory to find an expert near you. You can also join HealthTree's social media platform, HealthTree Connect to meet other patients and learn what they've done personally to live longer with Polycythemia Vera. 

Want to Learn More About Polycythemia Vera?

Keep reading HealthTree for Polycythemia Vera's 101 pages!

Get the latest thought leadership on Polycythemia Vera delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Polycythemia Vera Newsletter" for Polycythemia Vera news, life with Polycythemia Vera stories, Polycythemia Vera clinical trials, Polycythemia Vera 101 articles and events with Polycythemia Vera experts.

Follow Us

facebook twitter